Effector mechanisms of the anti-cancer immune responses of macrophages in SR/CR mice

Area of Science:

• Immunology
• Cancer Biology
• Innate Immunity

Background:

• Spontaneous regression/complete resistance (SR/CR) mice demonstrate remarkable resistance to lethal doses of cancer cells, unlike wild-type (WT) mice.
• The anti-tumor response in SR/CR mice involves innate immune leukocytes, including neutrophils, macrophages, and NK cells, infiltrating tumors.
• Cancer cells can be eliminated through necrosis in vivo or apoptosis induced by purified SR/CR macrophages.

Purpose of the Study:

• To elucidate the mechanisms by which SR/CR macrophages exert their tumoricidal activity.
• To investigate the role of specific effector molecules and cellular interactions in macrophage-mediated cancer cell killing.
• To determine if antibody-dependent cell-mediated cytotoxicity (ADCC) is involved in the anti-tumor response.

Main Methods:

• Isolation and purification of macrophages from SR/CR mice.
• Co-culture assays involving purified SR/CR macrophages and cancer cells.
• Analysis of effector molecules produced by macrophages, including reactive oxygen species (ROS) and serine proteases.
• Assessment of cancer cell death pathways (apoptosis, necrosis).
• Investigation of the role of antibodies and ADCC in macrophage-mediated cytotoxicity.

Main Results:

• SR/CR macrophages effectively killed cancer cells through direct cell contact.
• Macrophages utilized ROS and secreted serine proteases as primary cytotoxic mechanisms, inducing apoptosis in cancer cells.
• SR/CR macrophages did not rely on reactive nitrogen species (RNS) for tumoricidal activity.
• Antibodies produced by SR/CR mice were not essential for macrophage killing and did not confer killing ability to wild-type macrophages via ADCC.

Conclusions:

• SR/CR macrophages possess potent, contact-dependent cytotoxic capabilities against cancer cells.
• The primary killing mechanism involves ROS and serine proteases, leading to cancer cell apoptosis, not ADCC.
• These findings highlight a novel, non-ADCC macrophage-mediated anti-tumor pathway crucial for spontaneous cancer resistance.